Overjet in 2026: Usage, Revenue, Valuation & Growth Statistics

Artificial Intelligence is not just knocking on the doors of healthcare anymore, it has stepped in and completely redefined how care is delivered. In dentistry, the biggest breakthrough name is Overjet, an FDA-cleared AI platform built to analyze dental radiographs with precision and speed. By helping both insurers and dental clinics, Overjet has become one of the most important players in transforming oral healthcare in the modern age.

I’m Riten, founder of Fueler, a platform that helps freelancers and professionals get hired by showcasing their proof of work. Just like Overjet is reshaping dentistry with AI-backed evidence, I believe the future of careers will be built on proof, not promises. In this article, I’ll break down Overjet’s adoption, revenue, and valuation in 2026, highlighting how real-world evidence is driving trust at scale, whether in healthcare or in your personal portfolio.

Overjet, founded in 2018 by Dr. Wardah Inam, is a Boston-based startup that develops AI software for dental imaging. It assists dentists in detecting diseases more accurately from radiographs while also equipping insurance companies with tools to validate claims faster. Holding FDA clearance, Overjet is among the few dental AI startups that have made the leap from academic research to real-world adoption at scale.

FDA-Cleared AI for Radiographs

• Overjet is the first dental AI company to receive FDA clearance for analyzing bitewing and periapical dental X-rays. This approval is significant because it validates the technology’s safety and reliability in a clinical setting. Dentists using it can complement their expertise with machine-based precision that reduces errors and improves diagnoses.

Trusted by Dental Insurers Nationwide

• The company’s technology is heavily relied upon by major US dental insurers to speed up the claim review process. Overjet helps insurers verify the medical necessity behind a submitted claim by analyzing associated X-rays. This not only reduces fraudulent claims but also ensures patients get a fair evaluation without unnecessary disputes.

Consistency Across Group Practices (DSOs)

• Dental Service Organizations manage hundreds of clinics, and diagnostic consistency is often a challenge across multiple locations. Overjet provides these large networks with a standardized diagnostic framework so that every dentist applies the same quality standard. This removes the subjectivity of human interpretation and improves overall patient care outcomes.

Transparency for Patients

• A significant feature of Overjet is its ability to annotate dental X-rays with visual markers. Dentists can use these reports to walk patients through their oral health conditions in a language they actually understand. This builds trust with patients, makes conversations less technical, and significantly increases acceptance of treatment plans.

Shift from Treatment to Prevention

• Overjet is not just detecting issues after they occur but is also enabling early detection to support preventive dentistry. By flagging potential risks sooner, it helps clinics act before conditions worsen, saving patients from more painful and costly procedures. This emphasis on prevention aligns with the broader healthcare shift towards proactive care.

Usage Statistics in 2026

• Widespread insurer adoption in the US – Overjet has been publicly confirmed as a partner with leading dental insurers that collectively cover over 100 million Americans. This makes it one of the few dental AI startups widely embedded in insurance workflows, proving its credibility in underwriting and claims management.
• Deployment across Dental Service Organizations – Large DSOs, which often operate hundreds of affiliated clinics across the US, have adopted Overjet to maintain quality standards across their practices. While user counts are not disclosed, industry commentators consistently highlight Overjet as a leading AI solution used in everyday patient care across multiple states.
• Adoption by tens of thousands of dentists – While Overjet itself has not released exact dentist usage figures, it has acknowledged that DSO partnerships expose tens of thousands of dental professionals to its platform. This indicates its role as one of the most scaled dental AI solutions available in the US market today.

Revenue Statistics in 2026

• Private company, undisclosed earnings – As of 2026, Overjet has not published official revenue or ARR figures. Because it is a privately held company, financial data is released only during fundraising rounds or through investor reports.
• Enterprise SaaS revenue model – Overjet monetizes its solutions primarily through enterprise Software as a Service contracts. These are long-term recurring deals with DSOs and insurance providers rather than short-term, individually licensed software products.
• Stable high-value contracts – By embedding itself into insurer processes, Overjet creates multi-year and high-dollar partnerships. This revenue structure typically provides high predictability since insurers and DSOs cannot easily switch away from critical infrastructure once it is live.

Valuation Statistics in 2026

• Confirmed last round valuation – Overjet’s last publicly reported raise was a $53 million Series C in December 2022, led by General Catalyst and Insight Partners. At that point, its valuation was estimated around $425M by Crunchbase and PitchBook.
• No updated valuation disclosed – Since then, Overjet has not made new funding rounds public, meaning as of mid-2026, the verified valuation still stands at approximately $425M. Reports speculating about unicorn status have not been backed by the company or formal filings.
• Investor interest remains strong – Overjet’s FDA approval and unique positioning in dental AI continue to make it an attractive candidate for new funding. While growth is clear, the valuation ceiling remains officially tied to its last disclosed round.

Growth Statistics in 2026

• Scaling workforce significantly – Overjet grew from under 100 employees in 2021 to nearly 200 in 2022, based on job reports and investor disclosures. By 2026, hiring continues at pace, reflecting expansion in both technology and operations teams to manage its growing client base.
• Strong moat in the insurance sector – By building deep integrations with major US dental insurers, Overjet has effectively built switching costs that protect its position. Insurers rely on its FDA-cleared technology to validate millions of claims, making it difficult for newer players to displace Overjet.
• Positioned for global expansion – While still primarily focused on the US market, Overjet has signaled interest in international partnerships. Pilot conversations with non-US organizations have been reported, suggesting a potential global footprint in the near future.

Why it matters: These growth dynamics matter because they prove that Overjet has gone far beyond the pilot stage. Partnerships with insurers covering over 100 million Americans put it in the same category as infrastructure-level healthcare technology. Its FDA-clearance also sets it apart, showing that AI in dentistry is no longer “emerging” but an active, trusted part of the industry.

Where Fueler Fits In

Overjet builds patient trust by showing AI-backed proof in dental X-rays to demonstrate accuracy. Similarly, freelancers and professionals build trust by showcasing their proof of work through Fueler. Instead of only describing skills, you can display completed projects, real campaigns, or case studies. In both cases, credibility comes from visible evidence, not words.

Final Thoughts

Overjet’s story in 2026 isn’t about inflated numbers or hype, it’s about verified traction and regulatory wins. With FDA approvals, relationships with insurers serving over 100 million Americans, and deep integration into DSOs, it represents how AI can achieve meaningful adoption in healthcare. While revenue and valuation figures remain officially undisclosed, its proven role in everyday dental care makes it one of the most credible AI healthcare startups of the decade.

FAQs

Q1. Is Overjet FDA approved in 2026?

Yes, Overjet is FDA-cleared for identifying cavities and bone loss in dental radiographs. Being the first dental AI with this clearance, it is recognized as clinically safe and effective for use in real-world practices.

Q2. What is Overjet’s valuation in 2026?

Overjet’s last confirmed valuation was around $425 million after its $53M Series C in December 2022. No updated valuation has been disclosed as of 2026, meaning $425M is still the verified figure.

Q3. How many people does Overjet serve?

Overjet itself does not release usage statistics, but verified data shows it works with major insurers covering over 100 million Americans. Through DSOs, its technology reaches “tens of thousands of dentists” according to industry disclosures.

Q4. How much revenue does Overjet make?

Overjet, as a private company, has not released revenue or ARR figures publicly. What is known is that it runs on an enterprise SaaS model, with revenue largely dependent on long-term insurer and DSO contracts.

Q5. Does Overjet offer pricing for individual dentists?

No public subscription pricing for individual dentists is available. Overjet focuses primarily on enterprise contracts with large DSOs and insurance providers, where scale makes its technology more impactful and financially viable.

What is Fueler Portfolio?

Fueler is a career portfolio platform that helps companies find the best talent for their organization based on their proof of work. You can create your portfolio on Fueler, thousands of freelancers around the world use Fueler to create their professional-looking portfolios and become financially independent. Discover inspiration for your portfolio

Sign up for free on Fueler or get in touch to learn more.